Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


30.01.2017

2 AIDS
2 BMC Gastroenterol
2 Cancer
1 Eur J Gastroenterol Hepatol
8 Hepatology
1 Int J STD AIDS
1 J Clin Microbiol
3 J Hepatol
1 J Immunol
1 J Med Virol
6 J Viral Hepat
1 J Virol
1 Pediatr Infect Dis J
1 PLoS Comput Biol
10 PLoS One
1 Transplant Proc
1 Transplantation
1 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. SORIANO V, Sherman KE, Barreiro P
    Hepatitis Delta and HIV Infection.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001424.
    PubMed     Text format     Abstract available

  2. PINATO DJ, Pria AD, Sharma R, Bower M, et al
    Hepatocellular carcinoma: an evolving challenge in viral hepatitis and HIV co-infection.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001422.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  3. YOUSSEF NF, El Kassas M, Farag A, Shepherd A, et al
    Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt.
    BMC Gastroenterol. 2017;17:18.
    PubMed     Text format     Abstract available

  4. AN J, Lim YS, Kim GA, Han SB, et al
    Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial.
    BMC Gastroenterol. 2017;17:15.
    PubMed     Text format     Abstract available


    Cancer

  5. MAHALE P, Torres HA, Kramer JR, Hwang LY, et al
    Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry-based case-control study.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30559.
    PubMed     Text format     Abstract available

  6. LI D, Hurria A
    Age, hepatitis C virus infection, and the risk of cancer: Unlocking a complex puzzle of interactions.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30554.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  7. CHEN D, Luo S, Ben Q, Lu L, et al
    Prevalence of hepatitis B and C and factors for infection and nonimmune in inflammatory bowel disease patients in China.
    Eur J Gastroenterol Hepatol. 2017 Jan 21. doi: 10.1097/MEG.0000000000000838.
    PubMed     Text format     Abstract available


    Hepatology

  8. SMITH J, Rich J
    Addressing opioid use disorder in modeling hepatitis C transmission among persons who inject drugs.
    Hepatology. 2017 Jan 21. doi: 10.1002/hep.29070.
    PubMed     Text format    

  9. COUSIEN A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, et al
    Reply to "Addressing opioid use disorder in modeling hepatitis C transmission among persons who inject drugs".
    Hepatology. 2017 Jan 21. doi: 10.1002/hep.29069.
    PubMed     Text format    

  10. BERENGUER J, Rodriguez-Castellano E, Carrero A, Von Wichmann MA, et al
    Eradication of HCV and non-liver-related non-AIDS-related events in HIV/HCV coinfection.
    Hepatology. 2017 Jan 21. doi: 10.1002/hep.29071.
    PubMed     Text format     Abstract available

  11. THABET K, Chan HL, Petta S, Mangia A, et al
    The MBOAT7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.
    Hepatology. 2017 Jan 20. doi: 10.1002/hep.29064.
    PubMed     Text format     Abstract available

  12. SHIMIZU Y, Peltzer N, Sevko A, Lafont E, et al
    The linear ubiquitin chain assembly complex acts as a liver tumor suppressor and inhibits hepatocyte apoptosis and hepatitis.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29074.
    PubMed     Text format     Abstract available

  13. BISSONNETTE J, Altamirano J, Devue C, Roux O, et al
    A Prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29080.
    PubMed     Text format     Abstract available

  14. POORDAD F, Felizarta F, Asatryan A, Sulkowski MS, et al
    Glecaprevir and Pibrentasvir for 12 Weeks for HCV Genotype 1 Infection and Prior Direct-acting Antiviral Treatment.
    Hepatology. 2017 Jan 27. doi: 10.1002/hep.29081.
    PubMed     Text format     Abstract available

  15. PAUL S, Dickstein A, Saxena A, Terrin N, et al
    Role of Surface Antibody in Hepatitis B Reactivation in Patients with Resolved Infection and Hematologic Malignancy: A Meta-Analysis.
    Hepatology. 2017 Jan 27. doi: 10.1002/hep.29082.
    PubMed     Text format     Abstract available


    Int J STD AIDS

  16. ATEFI D, Pinto-Sander N, Richardson D
    Are testicular mixed germ cell tumours associated with hepatitis C (HCV) in HIV-positive men who have sex with men?
    Int J STD AIDS. 2017;28:208-209.
    PubMed     Text format    


    J Clin Microbiol

  17. VERMEHREN J, Stelzl E, Maasoumy B, Michel-Treil V, et al
    Multicenter comparison study of both analytical and clinical performance across 4 Roche HCV RNA assays utilizing different platforms.
    J Clin Microbiol. 2017 Jan 25. pii: JCM.02193-16. doi: 10.1128/JCM.02193.
    PubMed     Text format     Abstract available


    J Hepatol

  18. ROBERT O, Boujedidi H, Bigorgne A, Ferrere G, et al
    Decreased expression of the glucocorticoid receptor-GILZ pathway in Kupffer cells promotes liver inflammation in obese mice.
    J Hepatol. 2016;64:916-24.
    PubMed     Text format     Abstract available

  19. ZEUZEM S, Mizokami M, Pianko S, Mangia A, et al
    NS5A Resistance-Associated Substitutions in Patients with Genotype 1 Hepatitis C Virus: Prevalence and Effect on Treatment Outcome.
    J Hepatol. 2017 Jan 17. pii: S0168-8278(17)30011.
    PubMed     Text format     Abstract available

  20. FARQUHAR MJ, Humphreys IS, Rudge SA, Wilson GK, et al
    Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.
    J Hepatol. 2017 Jan 23. pii: S0168-8278(17)30013.
    PubMed     Text format     Abstract available


    J Immunol

  21. SAHA B, Kodys K, Adejumo A, Szabo G, et al
    Circulating and Exosome-Packaged Hepatitis C Single-Stranded RNA Induce Monocyte Differentiation via TLR7/8 to Polarized Macrophages and Fibrocytes.
    J Immunol. 2017 Jan 25. pii: 1600797. doi: 10.4049/jimmunol.1600797.
    PubMed     Text format     Abstract available


    J Med Virol

  22. HUNDIE GB, Raj VS, Gebre Michael D, Haagmans BL, et al
    Seroepidemiology of hepatitis B and C virus infections among blood donors in Ethiopia.
    J Med Virol. 2017 Jan 25. doi: 10.1002/jmv.24770.
    PubMed     Text format     Abstract available


    J Viral Hepat

  23. MENDIZABAL M, Reddy KR
    Chronic Hepatitis C and Chronic Kidney disease: Advances, Limitations and Unchartered Territories.
    J Viral Hepat. 2017 Jan 20. doi: 10.1111/jvh.12681.
    PubMed     Text format     Abstract available

  24. YU F, Zhou G, Huang K, Fan X, et al
    Serum lincRNA-p21 as a potential biomarker of liver fibrosis in chronic hepatitis B patients.
    J Viral Hepat. 2017 Jan 20. doi: 10.1111/jvh.12680.
    PubMed     Text format     Abstract available

  25. CHEN J, Xu CR, Xi M, Hu WW, et al
    Predictors of liver histological changes and a sustained response to peginterferon among chronic hepatitis B e antigen-positive patients with normal or minimally elevated alanine aminotransferase levels.
    J Viral Hepat. 2017 Jan 20. doi: 10.1111/jvh.12679.
    PubMed     Text format     Abstract available

  26. DIRKS M, Pflugrad H, Haag K, Tillmann HL, et al
    Persistent neuropsychiatric impairment in HCV patients despite clearance of the virus?!
    J Viral Hepat. 2017 Jan 24. doi: 10.1111/jvh.12674.
    PubMed     Text format     Abstract available

  27. TAIT JM, Wang H, Stephens BP, Miller M, et al
    Multidisciplinary managed care networks-Life-saving interventions for hepatitis C patients.
    J Viral Hepat. 2017;24:207-215.
    PubMed     Text format     Abstract available

  28. SMITH HL, Chung RT, Mantry P, Chapman W, et al
    Prevention of allograft HCV recurrence with peri-transplant human monoclonal antibody MBL-HCV1 combined with a single oral direct-acting antiviral: A proof-of-concept study.
    J Viral Hepat. 2017;24:197-206.
    PubMed     Text format     Abstract available


    J Virol

  29. CHEN J, Xu W, Chen Y, Xie X, et al
    MMP-9 Facilitates Hepatitis B Virus Replication through Binding with IFNAR1 to Repress IFN/JAK/STAT Signaling.
    J Virol. 2017 Jan 25. pii: JVI.01824-16. doi: 10.1128/JVI.01824.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  30. KUROSKY SK, Davis KL, Galindo CM
    Effect of Combination Vaccines on Hepatitis B Vaccine Compliance in Children in the United States.
    Pediatr Infect Dis J. 2017 Jan 17. doi: 10.1097/INF.0000000000001548.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  31. CHIANG AW, Wu WY, Wang T, Hwang MJ, et al
    Identification of Entry Factors Involved in Hepatitis C Virus Infection Based on Host-Mimicking Short Linear Motifs.
    PLoS Comput Biol. 2017;13:e1005368.
    PubMed     Text format     Abstract available


    PLoS One

  32. AHN HJ, Song MJ, Jang JW, Bae SH, et al
    Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea.
    PLoS One. 2017;12:e0170362.
    PubMed     Text format     Abstract available

  33. ZHAI N, Li H, Song H, Yang Y, et al
    Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling.
    PLoS One. 2017;12:e0170516.
    PubMed     Text format     Abstract available

  34. XING T, Xu H, Cao L, Ye M, et al
    HBeAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Nucleos(t)ide Analog Treatment: A Systematic Review and Network Meta-Analysis.
    PLoS One. 2017;12:e0169444.
    PubMed     Text format     Abstract available

  35. GAMBATO M, Caro-Perez N, Gonzalez P, Canete N, et al
    Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.
    PLoS One. 2017;12:e0170913.
    PubMed     Text format     Abstract available

  36. TSUTSUMI T, Okushin K, Enooku K, Fujinaga H, et al
    Nonstructural 5A Protein of Hepatitis C Virus Interferes with Toll-Like Receptor Signaling and Suppresses the Interferon Response in Mouse Liver.
    PLoS One. 2017;12:e0170461.
    PubMed     Text format     Abstract available

  37. NIEN HC, Hsu SJ, Su TH, Yang PJ, et al
    High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments.
    PLoS One. 2017;12:e0170028.
    PubMed     Text format     Abstract available

  38. INOUE T, Hmwe SS, Shimada N, Kato K, et al
    Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy.
    PLoS One. 2017;12:e0170667.
    PubMed     Text format     Abstract available

  39. APPELMAN MD, Chakraborty A, Protzer U, McKeating JA, et al
    N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection.
    PLoS One. 2017;12:e0170419.
    PubMed     Text format     Abstract available

  40. DEGRE D, Serste T, Lasser L, Delwaide J, et al
    Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium.
    PLoS One. 2017;12:e0170933.
    PubMed     Text format     Abstract available

  41. WU Q, An J, She R, Shi R, et al
    Detection of Genotype 4 Swine Hepatitis E Virus in Systemic Tissues in Cross-Species Infected Rabbits.
    PLoS One. 2017;12:e0171277.
    PubMed     Text format     Abstract available


    Transplant Proc

  42. MIYAAKI H, Tamada Y, Hayashi K, Taura N, et al
    Recurrent Hepatitis B and D Virus Infection in a Liver Transplant Recipient.
    Transplant Proc. 2017;49:175-177.
    PubMed     Text format     Abstract available


    Transplantation

  43. HIRATA Y, Yoshizawa A, Egawa H, Ueda D, et al
    Impact of Antibodies that React with Liver Tissue and Donor-specific anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis.
    Transplantation. 2017 Jan 23. doi: 10.1097/TP.0000000000001653.
    PubMed     Text format     Abstract available


    Vaccine

  44. ABARA WE, Collier MG, Teshale EH
    Impact of universal infant hepatitis B vaccination in the US-affiliated Pacific Islands, 1985-2015.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30039.
    PubMed     Text format     Abstract available


    Virology

  45. ZHANG F, Tang X, Garcia T, Lok AS, et al
    Characterization of contrasting features between hepatitis B virus genotype A and genotype D in small envelope protein expression and surface antigen secretion.
    Virology. 2017;503:52-61.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: